Guardant Health study links liquid biopsy test to melanoma recurrence risk

Go back to Guardant Health study links liquid biopsy test to melanoma recurrence risk
Textainer Group Holdings limited (NASDAQ: GH) Delayed: 166.66 --0 (-0%)
Previous Close $166.66    52 Week High $5.84 
Open $166.66    52 Week Low $5.49 
Day High $166.66    P/E N/A 
Day Low $166.66    EPS $0.00 
Volume 204